Paradigm Biocapital Advisors »

Immunovant shares owned by Paradigm Biocapital Advisors

Quarter-by-quarter ownership of Immunovant (IMVT) shares owned by Paradigm Biocapital Advisors from 13F filings

Historical chart of Paradigm Biocapital Advisors investment in Immunovant

Tip: Access up to 7 years of quarterly data

All positions including Immunovant held by Paradigm Biocapital Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Immunovant by Paradigm Biocapital Advisors

Quarter filed Position value Share count Share price at filing
2024-09-30 $39M 1.4M 28.51
2024-06-30 $36M 1.4M 26.40
2024-03-31 $26M 799k 32.31